KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Inventory Average (2019 - 2025)

Adaptive Biotechnologies' Inventory Average history spans 7 years, with the latest figure at $9.9 million for Q4 2025.

  • For Q4 2025, Inventory Average fell 3.15% year-over-year to $9.9 million; the TTM value through Dec 2025 reached $9.9 million, down 3.15%, while the annual FY2025 figure was $9.1 million, 20.22% down from the prior year.
  • Inventory Average for Q4 2025 was $9.9 million at Adaptive Biotechnologies, up from $9.2 million in the prior quarter.
  • Across five years, Inventory Average topped out at $20.1 million in Q1 2022 and bottomed at $8.5 million in Q2 2025.
  • The 5-year median for Inventory Average is $16.4 million (2022), against an average of $15.2 million.
  • The largest annual shift saw Inventory Average surged 73.2% in 2021 before it plummeted 39.91% in 2024.
  • A 5-year view of Inventory Average shows it stood at $18.7 million in 2021, then dropped by 15.19% to $15.9 million in 2022, then rose by 6.73% to $17.0 million in 2023, then tumbled by 39.91% to $10.2 million in 2024, then decreased by 3.15% to $9.9 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Inventory Average are $9.9 million (Q4 2025), $9.2 million (Q3 2025), and $8.5 million (Q2 2025).